COMPANY PROFILE / #3402
Biolexis Therapeutics
Lehi, UTVenture Capital-Backed
OVERVIEW
Developer of an AI-enabled discovery platform designed to create potent and selective small molecule therapeutics. The company's technology leverages a library of proprietary fragments against each of the available protein targets from almost all real or empirical data points and scaffold-like compounds, enabling medical professionals to design rapid discovery and development of novel clinical candidate agents for a variety of therapeutic applications, new for diseases of immunology, oncology, and metabolism.
已融资11.50
最新估值31.50
员工数9
成立年份2021
公司概况
- Companies
- Biolexis Therapeutics
- Description
- Developer of an AI-enabled discovery platform designed to create potent and selective small molecule therapeutics. The company's technology leverages a library of proprietary fragments against each of the available protein targets from almost all real or empirical data points and scaffold-like compounds, enabling medical professionals to design rapid discovery and development of novel clinical candidate agents for a variety of therapeutic applications, new for diseases of immunology, oncology, and metabolism.
- Website
- www.biolexistx.com
- HQ Location
- Lehi, UT
- Year Founded
- 2021
- Keywords
- autoimmune drug maker, biotechnology research, drug discovery firm, metabolic drugs, small molecule therapeutics, therapeutics research
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 11.50
- First Financing Date
- 14-Feb-2022
- First Financing Size
- 1.50
- First Financing Valuation
- 21.50
- Last Financing Date
- 29-Nov-2023
- Last Financing Deal Type
- Early Stage VC
- Last Financing Size
- 10.00
- Last Financing Valuation
- 31.50
- Last Financing Status
- Completed
- Last Known Valuation
- 31.50
- Last Known Valuation Date
- 29-Nov-2023
- Last Known Valuation Deal Type
- Early Stage VC
- Valuation Estimate
- 46.69
- Valuation Estimate Growth Rate
- 48.21%
- Active Investors
- Clarke Capital Partners
- # Active Investors
- 1
- Acquirers
- —
团队与联系人
- Employees
- 9
- Employee Growth %
- 0.00%
- Employee History
- 2023: 9, 2022: 9
- Primary Contact
- David Taylor
- Primary Contact Title
- Chief Financial Officer
- Primary Contact Email
- dtaylor@biolexistx.com
- Primary Contact Phone
- +1 (801) 550-8088
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- —
- Growth Rate % Change
- —
- Growth Rate Percentile
- —
- Size Multiple
- —
- Size Multiple % Change
- —
- Size Multiple Change
- —
- Size Multiple Percentile
- —
- Majestic Referring Domains
- —
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- —
- Success Probability Over Time – 3 Year
- —
- Success Probability Over Time – 5 Year
- —
记录来源：public.companies · 原始序号 #3402 · 所有字段均按数据库原值展示。